Clinical Trials in Negrar, Verona
8 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 2
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Crohn's Disease
AbbVie540 enrolled254 locationsNCT06548542
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Crohn's Disease
Merck Sharp & Dohme LLC1,200 enrolled497 locationsNCT06430801
Recruiting
A Study to Assess the Effectiveness of Second-Line Therapy of Upadacitinib and Risankizumab in Adult Participants With Crohn's Disease in a Real-World Setting
Crohn's Disease
AbbVie250 enrolled23 locationsNCT07073079
Recruiting
Stereotactic Body Radiotherapy (SBRT) for Reirradiation of Inoperable Lung Lesions
Non-small Cell Lung CancerPulmonary Stereotactic Radiotherapy
Istituto Clinico Humanitas150 enrolled11 locationsNCT07401615
Recruiting
PulseSelect™ PFA Global Registry
Atrial Fibrillation
Medtronic Cardiac Ablation Solutions1,950 enrolled28 locationsNCT06393920
Recruiting
Not Applicable
Low and Intermediate Risk OliGometastatic ColoREctal CancEr PatieNts Treated with Stereotactic ABlative Radiotherapy
Colorectal, Cancer
IRCCS Sacro Cuore Don Calabria di Negrar204 enrolled1 locationNCT06310564
Recruiting
Not Applicable
Timing to Minimally Invasive Surgery After Neoadjuvant Chemoradiotherapy for Rectal Cancer
Rectal Cancer
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria340 enrolled14 locationsNCT03465982
Recruiting
Not Applicable
Daily Adaptive RadioTherapy in Postoperative HypofrActionated Salvage radiothERapy for Prostate Cancer Patients
Prostate Cancer
IRCCS Sacro Cuore Don Calabria di Negrar184 enrolled1 locationNCT05884632